MA
CYTK icon

MUFG Americas’s Cytokinetics CYTK Stock Holding History

MUFG Americas’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-910
Closed -$6K – 1112
2016
Q1 		$6K Sell
910
-610
-40% -$4.46K ﹤0.01% 898
2015
Q4 		$16K Sell
1,520
-2,240
-60% -$22K ﹤0.01% 745
2015
Q3 		$25K Sell
3,760
-288
-7% -$1.97K ﹤0.01% 694
2015
Q2 		$27K Buy
4,048
+578
+17% +$3.79K ﹤0.01% 703
2015
Q1 		$24K Buy
3,470
+710
+26% +$5.3K ﹤0.01% 777
2014
Q4 		$22K Buy
2,760
+1,070
+63% +$4.59K ﹤0.01% 802
2014
Q3 		$6K Buy
+1,690
New +$7.1K ﹤0.01% 1044

Other funds holding CYTK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

MUFG Americas's CYTK Position: Q2 2016 in Review

MUFG Americas sold out of Cytokinetics (CYTK) in Q2 2016, closing a stake of 910 shares — an estimated $6K sold.

MUFG Americas first reported a position in CYTK in Q3 2014 and held it in 7 quarters. The position peaked at $27K in Q2 2015. 95 funds tracked by Wall St. Rank hold CYTK as of Q2 2016.

  • MUFG Americas reported no remaining Cytokinetics position as of Q2 2016 after selling out during the quarter.
  • MUFG Americas sold 910 Cytokinetics shares in Q2 2016, an estimated $6K.
  • MUFG Americas first reported a position in Cytokinetics in Q3 2014 and held it in 7 quarters.
  • MUFG Americas's Cytokinetics position peaked at $27K in Q2 2015.
  • 95 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2016.

Based on MUFG Americas's 13F filing for Q2 2016, filed 8 Aug 2016.